Drugs / Xiyanping injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04926506 | Oct 2021 → Sep 2022 | bronchitis | Jiangxi Qingfeng Pharmaceutical Co. Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiyanping injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04926506 ↗ |
| Route | Intramuscular | “Intramuscular injection of Xiyanping injection” NCT04926506 ↗ |